» Articles » PMID: 32752018

Proteomic Research in Peritoneal Dialysis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Aug 6
PMID 32752018
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Peritoneal dialysis (PD) is an established home care, cost-effective renal replacement therapy (RRT), which offers several advantages over the most used dialysis modality, hemodialysis. Despite its potential benefits, however, PD is an under-prescribed method of treating uremic patients. Infectious complications (primarily peritonitis) and bio-incompatibility of PD solutions are the main contributors to PD drop-out, due to their potential for altering the functional and anatomical integrity of the peritoneal membrane. To improve the clinical outcome of PD, there is a need for biomarkers to identify patients at risk of PD-related complications and to guide personalized interventions. Several recent studies have shown that proteomic investigation may be a powerful tool in the prediction, early diagnosis, prognostic assessment, and therapeutic monitoring of patients on PD. Indeed, analysis of the proteome present in PD effluent has uncovered several proteins involved in inflammation and pro-fibrotic insult, in encapsulating peritoneal sclerosis, or even in detecting early changes before any measurable modifications occur in the traditional clinical parameters used to evaluate PD efficacy. We here review the proteomic studies conducted thus far, addressing the potential use of such omics methodology in identifying potential new biomarkers of the peritoneal membrane welfare in relation to dialytic prescription and adequacy.

Citing Articles

A rare case of successful treatment of peritoneal dialysis patient with peritonitis without catheter removal: case report and literature review.

Xie R, Ling Y, Huang Y, Qin L, Bao K, Qin X Front Cell Infect Microbiol. 2024; 14:1373036.

PMID: 38873095 PMC: 11169698. DOI: 10.3389/fcimb.2024.1373036.


Coupling Osmotic Efficacy with Biocompatibility in Peritoneal Dialysis: A Stiff Challenge.

Bonomini M, Masola V, Monaco M, Sirolli V, Di Liberato L, Prosdocimi T Int J Mol Sci. 2024; 25(6).

PMID: 38542505 PMC: 10971259. DOI: 10.3390/ijms25063532.


Potential of Autologous Adipose-Derived Mesenchymal Stem Cells in Peritoneal Fibrosis: A Pilot Study.

Ahmadi A, Moghadasali R, Najafi I, Shekarchian S, Alatab S Arch Iran Med. 2023; 26(2):100-109.

PMID: 37543930 PMC: 10685899. DOI: 10.34172/aim.2023.16.


Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review.

Sirolli V, Piscitani L, Bonomini M Int J Mol Sci. 2023; 24(6).

PMID: 36982359 PMC: 10049725. DOI: 10.3390/ijms24065287.


Proteome-Wide Differential Effects of Peritoneal Dialysis Fluid Properties in an In Vitro Human Endothelial Cell Model.

Sacnun J, Hoogenboom R, Eibensteiner F, Sobieszek I, Unterwurzacher M, Wagner A Int J Mol Sci. 2022; 23(14).

PMID: 35887356 PMC: 9317527. DOI: 10.3390/ijms23148010.


References
1.
Ruiz-Carpio V, Sandoval P, Aguilera A, Albar-Vizcaino P, Perez-Lozano M, Gonzalez-Mateo G . Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients. Sci Rep. 2017; 7:44941. PMC: 5361179. DOI: 10.1038/srep44941. View

2.
Yee-Moon Wang A, Dong J, Xu X, Davies S . Volume management as a key dimension of a high-quality PD prescription. Perit Dial Int. 2020; 40(3):282-292. DOI: 10.1177/0896860819895365. View

3.
Singh S, Heijmans R, Meulen C, Lieverse A, Gornik O, Sijbrands E . Association of the IgG -glycome with the course of kidney function in type 2 diabetes. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7213753. DOI: 10.1136/bmjdrc-2019-001026. View

4.
Betjes M, Habib S, Boeschoten E, Hemke A, Struijk D, Westerhuis R . Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients. Perit Dial Int. 2017; 37(2):230-234. DOI: 10.3747/pdi.2016.00109. View

5.
Zhang L, Wen Q, Mao H, Luo N, Rong R, Fan J . Developing a reproducible method for the high-resolution separation of peritoneal dialysate proteins on 2-D gels. Protein Expr Purif. 2013; 89(2):196-202. DOI: 10.1016/j.pep.2013.03.010. View